IMNM icon

Immunome

120 hedge funds and large institutions have $566M invested in Immunome in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 38 increasing their positions, 35 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.57% less ownership

Funds ownership: 85.98%85.41% (-0.57%)

25% less capital invested

Capital invested by funds: $755M → $566M (-$188M)

98% less call options, than puts

Call options by funds: $439K | Put options by funds: $21.9M

Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$439K
Puts
$21.9M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
51
$536K
52
$512K
53
$489K
54
$486K
55
$471K
56
$466K
57
$456K
58
$446K
59
$441K
60
$397K
61
$379K
62
$378K
63
$343K
64
$293K
65
$283K
66
$278K
67
$274K
68
$271K
69
$270K
70
$263K
71
$244K
72
$212K
73
$202K
74
$202K
75
$201K